November 2, 2022 – Vancouver, British Columbia –  Delivra Health Brands Inc. ("Delivra Health" or the "Company") (TSX-V: DHB; OTCQB: DHBUF), a consumer packaged goods (“CPG”) leader uniquely positioned in the health and wellness sector, announced today that its wholly-owned subsidiary, Dream Products USA Inc., has further expanded its distribution in the United States with the signing of a sales and distribution agreement (the “Agreement”) dated November 1, 2022 with Casey’s General Stores (“Casey’s”), a leading North American convenience store chain with over 2,400 locations.

Gord Davey, President and CEO of Delivra Health said, “Further to our growth objectives, our team has focused on the development of new emerging channel partners, which we have achieved through the signing of the Agreement, extending distribution to over 2,400 new Casey’s locations. These relationships, complemented by our existing partners and network in North America, will accelerate distribution, brand awareness and product trial. This expanded network is exciting news as it will foster additional growth of the Company’s existing CPG brand, Dream Water^TM , and set the Company up for future success with our anticipated line extensions of both cannabis infused and non-infused products.”

For more information about Casey’s, please visit their website at: www.caseys.com.

In addition to the above, the Company announces it has granted certain directors, officers and employees of the Company an aggregate of 4,900,000 options to purchase common shares in the capital of the Company pursuant to its share option plan. The options are exercisable at a price of $0.05 per common share and will have a term of five years from the date of grant.

About Delivra Health Brands Inc.

Helping people take control of their health with alternative wellness solutions is what energizes the Delivra Health team! The Delivra Health portfolio features innovative brands like Dream Water™ and LivRelief™, which deliver relief from common everyday issues like chronic pain, anxiety, and sleeplessness. Delivra Health products have allowed millions of customers to reclaim their mobility, energy, and in turn, quality of life.  The websites of the Company’s two subsidiaries are  Dream Water™ and  LivRelief^TM. For more information, please visit  www.delivrahealthbrands.com. 

Cautionary Note Regarding Forward-Looking Statements

This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates, and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements include, among other things, statements with respect to the Company’s growth objectives, new channel and distribution partners, acceleration of distribution, brand awareness, and product trial and future line extensions of cannabis infused and non-infused products.

These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of the Company to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: implications of the COVID-19 pandemic on the Company's operations; fluctuations in general macroeconomic conditions; fluctuations in securities markets; expectations regarding the size of the cannabis markets where the Company operates; changing consumer habits; the ability of the Company to successfully achieve its business objectives; plans for expansion; political and social uncertainties; inability to obtain adequate insurance to cover risks and hazards; employee relations and the presence of laws and regulations that may impose restrictions on cultivation, production, distribution, and sale of cannabis and cannabis-related products in the markets where the Company operates. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.

Additional information regarding this and other risks and uncertainties relating to the Company's business are contained under the heading "Risk Factors" in the Company's annual information form dated March 2, 2021, and under the heading "Risks and Uncertainties" in the Company's management's discussion and analysis dated October 28, 2022, for the year ended June 30, 2022, filed under the Company's profile on SEDAR at www.sedar.com.

Neither TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accept responsibility for the adequacy or accuracy of this release.

Investor Relations:
Jack Tasse
Chief Financial Officer
IR@delivrahealth.com
1-877-915-7934